Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

NCT02314923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Ebola Virus

Interventions

BIOLOGICAL: V920 Vaccine
OTHER: Placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]
[object Object]